Plain-English translation of NCT03821246 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether —a medication that helps your immune system fight cancer—given before prostate surgery can improve treatment outcomes for men with localized prostate cancer. Researchers will also test this medication combined with one or two additional drugs to see which approach works best. The goal is to understand how these treatments change your immune system's ability to attack cancer cells.
Currently, men with localized prostate cancer typically go straight to surgery. This trial exists to see whether giving immune-boosting treatment before surgery might help the body's immune system better control the cancer, potentially improving long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive one intravenous infusion of the medication (given through a vein over 30–60 minutes), and depending on which group you're assigned to, you may also take an oral pill daily for about 12 days. About 3 weeks after the infusion, you would undergo your scheduled prostate surgery. Researchers will study tumor samples and blood samples collected before and after treatment to understand how the medication affects your immune system.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States